Key facts
- This page summarizes William P. Noglows's Form 4 filing for ASPEN AEROGELS INC (ASPN).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 31 May 2024, 18:36.
William P. Noglows - 30 May 2024 Form 4 Insider Report for ASPEN AEROGELS INC (ASPN)
- Reporting relationship
- Director
- Issuer ticker
- ASPN
- Reported as of
- 30 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 31 May 2024, 18:36:56 UTC
- Prior SEC filing
- 29 Apr 2024
- Next SEC filing
- 10 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Virginia H. Johnson, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William P. Noglows filed Form 4 for ASPEN AEROGELS INC (ASPN) on 31 May 2024.
Change
- Previous filing in this sequence was filed on 29 Apr 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ASPN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,898
- Change %
- +2.5%
- Price
- $0.000000
- Shares after
- 78,617
- Date
- 30 May 2024
- Ownership
- Direct
- Footnotes
- F1
ASPN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- 0
- Change %
- 0%
- Price
- $0.000000*
- Shares after
- 10,000
- Date
- 30 May 2024
- Ownership
- See footnote 2
- Footnotes
- F2
ASPN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- 0
- Change %
- 0%
- Price
- $0.000000*
- Shares after
- 10,000
- Date
- 30 May 2024
- Ownership
- See footnote 3
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ASPN
transaction
Derivative
Stock Options (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +1,657
- Change %
- Price
- $0.000000
- Shares after
- 1,657
- Date
- 30 May 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,657
- Exercise price
- $29.50
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) May 30, 2025, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2025.
Footnote F2
These shares of Common Stock are held by a Trust for the benefit of one of the reporting person's children, of which the reporting person is the Trustee.
Footnote F3
These shares of Common Stock are held by a Trust for the benefit of another one of the reporting person's children, of which the reporting person is the Trustee.
Footnote F4
The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) May 30, 2025, or (b) the day prior to the Issuer's annual